Machine Learning Times
Machine Learning Times
EXCLUSIVE HIGHLIGHTS
The Rise Of Large Database Models
 Originally published in Forbes Even as large language models have...
3 Predictions For Predictive AI In 2025
 Originally published in Forbes GenAI’s complementary sibling, predictive AI, makes...
The Quant’s Dilemma: Subjectivity In Predictive AI’s Value
 Originally published in Forbes This is the third of a...
To Deploy Predictive AI, You Must Navigate These Tradeoffs
 Originally published in Forbes This is the second of a...
SHARE THIS:

10 years ago
Video: Predictive Analytics: Advancing Precision and Population Medicine

 

This speaker session is from Predictive Analytics World for Healthcare, October, 5–9, 2014 in Boston, MA:

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.

 George Savage is the Chief Medical Officer and co-founder of Proteus Digital Health, and formerly the company’s vice president of research and development. Dr. Savage has started ten companies since 1989 as entrepreneur or founding investor, including FemRx (acquired by Johnson and Johnson), CardioRhythm (acquired by Medtronic) and QRx Pharmaceuticals (ASX IPO). Dr. Savage holds a B.S. in biomedical engineering from Boston University, where he graduated magna cum laude and Tau Beta Pi, an M.D. from Tufts University School of Medicine and an M.B.A. from Stanford University Graduate School of Business. Dr. Savage serves on the boards of

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.